LTFS
IOVA icon

Ladenburg Thalmann Financial Services’s Iovance Biotherapeutics IOVA Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$205K Buy
7,402
+102
+1% +$2.32K ﹤0.01% 2476
2019
Q3 		$133K Sell
7,300
-400
-5% -$8.85K ﹤0.01% 2749
2019
Q2 		$189K Buy
7,700
+1,000
+15% +$15.1K ﹤0.01% 2514
2019
Q1 		$64K Sell
6,700
-468
-7% -$4.55K ﹤0.01% 3231
2018
Q4 		$63K Sell
7,168
-1,000
-12% -$9.64K ﹤0.01% 3097
2018
Q3 		$92K Buy
8,168
+2,468
+43% +$35K ﹤0.01% 2884
2018
Q2 		$96K Hold
5,700
– – ﹤0.01% 2780
2018
Q1 		$96K Buy
5,700
+3,275
+135% +$49.6K ﹤0.01% 2780
2017
Q4 		$20K Buy
2,425
+200
+9% +$1.61K ﹤0.01% 3803
2017
Q3 		$18K Hold
2,225
– – ﹤0.01% 3737
2017
Q2 		$17K Sell
2,225
-3,650
-62% -$23.2K ﹤0.01% 3701
2017
Q1 		$44K Hold
5,875
– – ﹤0.01% 3008
2016
Q4 		$41K Hold
5,875
– – ﹤0.01% 2983
2016
Q3 		$48K Buy
5,875
+4,650
+380% +$39.3K ﹤0.01% 2806
2016
Q2 		$10K Hold
1,225
– – ﹤0.01% 3774
2016
Q1 		$6K Sell
1,225
-500
-29% -$2.74K ﹤0.01% 3974
2015
Q4 		$14K Buy
1,725
+225
+15% +$1.56K ﹤0.01% 3471
2015
Q3 		$9K Hold
1,500
– – ﹤0.01% 3592
2015
Q2 		$14K Hold
1,500
– – ﹤0.01% 3461
2015
Q1 		$18K Buy
+1,500
New +$16.9K ﹤0.01% 3249

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ladenburg Thalmann Financial Services's IOVA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Iovance Biotherapeutics (IOVA) stake by 1.4% in Q4 2019, buying an estimated $2.32K and bringing the position to 7,402 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

Ladenburg Thalmann Financial Services first reported a position in IOVA in Q1 2015 and has held it in 20 quarters since. 200 funds tracked by Wall St. Rank hold IOVA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 7,402 shares of Iovance Biotherapeutics worth $205K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 102 Iovance Biotherapeutics shares in Q4 2019, an estimated $2.32K.
  • Iovance Biotherapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2476 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Iovance Biotherapeutics in Q1 2015 and has held it in 20 quarters since.
  • 200 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.